Patents Assigned to Ind-Swift Laboratories Limited
  • Patent number: 8912325
    Abstract: Disclosed is a process for the preparation of imatinib of formula (I), or its mesylate salt with controlled level of genotoxic impurity of formula (II), a key intermediate for imatinib.
    Type: Grant
    Filed: March 27, 2012
    Date of Patent: December 16, 2014
    Assignee: Ind-Swift Laboratories Limited
    Inventors: Bhaskar Bhirud Shekhar, Kumar Jain Anshul, Kumar Sharma Ajay
  • Patent number: 8552219
    Abstract: Provided is a process for the preparing 1-phenyl-3-dimethylaminopropane derivatives of formula I, (The formula should be inserted here) and its pharmaceutically acceptable salts thereof via novel intermediates.
    Type: Grant
    Filed: September 20, 2011
    Date of Patent: October 8, 2013
    Assignee: Ind-Swift Laboratories Limited
    Inventors: Shekhar Bhaskar Bhirud, Perminder Singh Johar, Sushanta Mishra, Danish Jamshad
  • Patent number: 8212026
    Abstract: The present invention encompasses a process for the preparation of highly pure ivabradine hydrochloride by treating ivabradine with alcoholic hydrogen chloride. The invention further encompasses amorphous ivabradine hydrochloride and process for its preparation using suitable acid addition salts of ivabradine.
    Type: Grant
    Filed: May 29, 2008
    Date of Patent: July 3, 2012
    Assignee: Ind-Swift Laboratories Limited
    Inventors: Satyendra Pal Singh, Gajendra Singh, Lalit Wadhwa
  • Patent number: 8076483
    Abstract: The present invention relates to an industrially advantageous process of making bisphosphonic acid or its salt in particular risedronic acid, [1-hydroxy-2(3-pyridinyl)ethylidene]bisphosphonic acid, having formula-(I) or its salts in high purity and high yields.
    Type: Grant
    Filed: May 9, 2007
    Date of Patent: December 13, 2011
    Assignee: M/s. Ind Swift Laboratories Limited
    Inventors: Saxena Rahul, Jain Anshul Kumar, Srinivasan Chidambaram Venkateswaran, Wadhwa Lalit